Susquehanna International Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.6K Buy
135,773
+47,318
+53% +$74.4K ﹤0.01% 12665
2025
Q4
$274K Buy
+88,455
New +$252K ﹤0.01% 10155
2025
Q3
Sell
-382,677
Closed -$843K 12970
2025
Q2
$471K Sell
382,677
-2,533,432
-87% -$2.76M ﹤0.01% 9316
2025
Q1
$3.21M Buy
2,916,109
+2,338,235
+405% +$2.7M ﹤0.01% 4521
2024
Q4
$523K Buy
577,874
+226,913
+65% +$194K ﹤0.01% 8554
2024
Q3
$346K Buy
350,961
+17,367
+5% +$16.7K ﹤0.01% 9293
2024
Q2
$301K Sell
333,594
-1,478,811
-82% -$1.11M ﹤0.01% 9442
2024
Q1
$2.14M Buy
1,812,405
+1,312,583
+263% +$1.44M ﹤0.01% 5178
2023
Q4
$456K Sell
499,822
-64,481
-11% -$47.6K ﹤0.01% 8900
2023
Q3
$470K Sell
564,303
-185,679
-25% -$214K ﹤0.01% 8370
2023
Q2
$900K Sell
749,982
-1,208,072
-62% -$1.5M ﹤0.01% 6934
2023
Q1
$2.47M Buy
1,958,054
+1,688,552
+627% +$3.23M ﹤0.01% 4713
2022
Q4
$585K Buy
269,502
+176,047
+188% +$1.45M ﹤0.01% 7438
2022
Q3
$1.12M Buy
+93,455
New +$1.16M ﹤0.01% 6338
2022
Q2
Sell
-52,082
Closed -$404K 13273
2022
Q1
$452K Sell
52,082
-21,394
-29% -$206K ﹤0.01% 9229
2021
Q4
$831K Buy
73,476
+34,250
+87% +$407K ﹤0.01% 7788
2021
Q3
$493K Sell
39,226
-38,445
-49% -$354K ﹤0.01% 9435
2021
Q2
$631K Buy
77,671
+10,506
+16% +$91.1K ﹤0.01% 8997
2021
Q1
$621K Sell
67,165
-62,709
-48% -$632K ﹤0.01% 8969
2020
Q4
$1.26M Buy
129,874
+7,106
+6% +$70K ﹤0.01% 6156
2020
Q3
$1.52M Buy
+122,768
New +$1.63M ﹤0.01% 5147
2020
Q2
Sell
-96,128
Closed -$1.21M 10403
2020
Q1
$976K Buy
+96,128
New +$1.26M ﹤0.01% 5465
2019
Q4
Sell
-50,778
Closed -$1.02M 10036
2019
Q3
$853K Buy
+50,778
New +$1.01M ﹤0.01% 6046

Other funds holding GOSS

Susquehanna International Group's GOSS Position: Q1 2026 in Review

Susquehanna International Group increased its Gossamer Bio (GOSS) stake by 53% in Q1 2026, buying an estimated $74.4K and bringing the position to 135,773 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #12665.

Susquehanna International Group first reported a position in GOSS in Q3 2019 and has held it in 23 quarters since. The position peaked at $3.21M in Q1 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Susquehanna International Group held 135,773 shares of Gossamer Bio worth $44.6K as of Q1 2026.
  • Susquehanna International Group bought 47,318 Gossamer Bio shares in Q1 2026, an estimated $74.4K.
  • Gossamer Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12665 holding.
  • Susquehanna International Group first reported a position in Gossamer Bio in Q3 2019 and has held it in 23 quarters since.
  • Susquehanna International Group's Gossamer Bio position peaked at $3.21M in Q1 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.